Caribou Biosciences CRBU Cash Flow Statement (2020-2026)

NASDAQ CRBU
$0.39 -0.02 (-4.80%)
At close: Nov 11, 2026 · 4:00 PM EST
Reported Financials

Caribou Biosciences Quarterly Cash Flow Statement

Periods 27 quarters
Latest Sep 2026

Caribou Biosciences reported cash from operations of -$22.50M and free cash flow of -$22.52M for the quarter ended Sep 2026, up 10.7% year over year. This cash flow statement covers 27 quarters of results from Mar 2020 through Sep 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026 Sep2026
Operating Activities
Net Income
-18.48M-19.09M-26.70M-26.65M-26.99M-28.04M-29.52M-10.00M-34.51M-41.23M-37.70M-34.68M-35.49M-39.99M-54.10M-27.55M-26.49M-25.09M-24.28M-26.61M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF)Dep. & Amort.
0.27M0.31M0.36M0.45M0.51M0.59M0.62M1.58M0.74M0.71M0.86M1.18M1.18M1.17M1.17M0.63M0.68M0.65M0.63M0.59M
Share-based CompensationStock Comp.
1.58M3.02M2.92M2.67M3.10M3.13M3.59M3.48M3.56M3.99M4.74M4.07M3.91M3.88M3.13M2.93M2.74M2.36M2.48M2.16M
Gains from Sales and DivestituresGains Divest
0.00M0.03M0.00M0.01M0.25M
Gains from Investment SecuritiesGains Investment
-0.09M-0.02M0.03M-0.06M-0.02M0.02M0.00M-0.01M-0.10M-0.01M0.01M-0.01M0.02M0.01M-0.12M
Asset Writedowns and ImpairmentWritedown
9.20M12.15M0.05M
Other non-cash itemsOther Non-Cash
-2.16M-1.10M-1.05M1.61M-1.29M0.26M-0.28M0.14M2.18M0.22M-1.80M0.16M0.26M0.16M-0.45M0.42M0.32M0.32M0.33M
Change in Working Capital
Change in ReceivablesChange Receivables
0.58M-0.78M0.15M-0.13M-0.20M1.33M-0.77M0.37M-0.99M0.77M-0.70M-0.03M0.08M-0.18M-0.02M0.17M-0.17M0.16M-0.02M0.32M
Change in Account PayablesChange Payables
0.29M-1.92M-1.64M0.99M-0.15M1.50M0.54M-0.95M0.73M2.72M-2.37M-0.48M-0.23M1.40M-0.63M0.56M1.92M-2.22M-0.42M1.97M
Change in Accrued ExpensesChange Accrued Exp.
-0.57M-2.83M3.95M-0.21M1.04M-4.14M3.71M3.28M2.90M-2.20M4.97M1.58M-2.21M-3.10M0.69M-1.11M-2.82M-2.65M-0.74M0.13M
Change in Other Operating AssetsOther Assets Change
1.21M0.48M-1.59M0.71M-0.57M-3.03M-0.94M2.68M-1.19M-0.05M-0.75M3.15M1.29M-1.28M-1.70M-0.33M-3.79M-1.36M-0.40M-0.08M
Change in Other Operating LiabilitiesOther Liabilities Change
-0.59M-0.67M-2.00M-0.90M-1.79M-1.42M6.14M-21.35M-0.78M-0.64M-1.19M-0.81M-0.49M-1.26M-1.22M-1.02M-1.20M-1.29M-1.14M-0.37M
Other Working Capital ChangesOther WC Changes
-1.80M-1.14M-0.42M-1.62M-1.21M1.61M7.08M-24.03M0.41M-0.60M-0.44M-3.96M-1.79M0.02M0.48M-0.69M2.59M0.07M-0.74M-0.29M
Cash from OperationsCash from Ops.
-21.39M-21.67M-21.87M-22.38M-25.04M-27.94M-15.19M-28.79M-21.38M-37.20M-32.87M-32.66M-35.47M-36.73M-28.26M-25.19M-20.83M-27.00M-22.80M-22.50M
Investing Activities
Capital ExpendituresCapex
0.69M0.72M2.62M1.35M1.76M2.03M2.55M4.75M2.28M1.45M2.24M0.67M0.52M1.04M0.42M0.12M-0.22M0.07M0.00M0.02M
Change in Property, Plant and EquipmentChange in PP&E
-0.69M-0.72M-2.62M-1.35M-1.76M-2.03M-2.55M-4.75M-2.28M-1.45M-2.24M-0.67M-0.52M-1.04M-0.42M-0.12M0.22M-0.07M0.00M-0.02M
Change in IntangiblesChange Intangibless
0.30M1.50M0.13M
Purchase of InvestmentsInvestments Purchased
173.28M110.68M71.06M70.81M86.51M75.93M58.74M175.89M84.19M71.18M84.24M93.47M55.50M15.53M32.22M57.45M44.03M22.09M20.50M15.94M
Sale and Maturity of InvestmentsInvestments Sold
78.60M119.42M128.24M179.48M98.67M72.36M112.17M55.00M97.09M107.80M120.66M71.94M65.96M56.67M68.41M61.79M46.14M39.45M35.04M
Other Investing Activities (as filed)Other investing (as filed)
0.05M0.05M0.05M0.05M0.05M-0.05M
Cash from Investing ActivitiesCash from Investing
-173.96M-72.11M-13.97M-8.34M1.17M20.70M11.06M-68.48M-31.47M22.96M21.20M26.52M15.93M49.38M24.04M10.85M17.97M23.99M18.94M19.39M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt IssuancesLT Debt Issuance
Long-Term Debt RepaymentsLT Debt Repayment
Net Long-Term Debt Issued (Repaid)Net LT Debt
Net Debt Issuances and RepaymentsNet Debt Issuance
Change in Capital Stock
Common Stock IssuedStock Issued
0.46M0.99M0.36M0.65M0.13M1.64M17.57M0.59M0.07M12.49M0.13M0.24M3.86M0.47M0.01M0.28M4.07M2.70M17.94M2.99M
Net Shares Issued and RepurchasedNet Shares Issued
0.46M0.99M0.36M0.65M0.13M1.64M17.57M0.59M0.07M12.49M0.13M0.24M3.86M0.47M0.01M0.28M4.07M2.70M17.94M2.99M
Net Preferred Shares Issued and RepurchasedNet Pref. Shares Issued
Net Equity Issued and RepurchasedNet Equity Issued
0.46M0.99M0.36M0.65M0.13M1.64M17.57M0.59M0.07M12.49M0.13M0.24M3.86M0.47M0.01M0.28M4.07M2.70M17.94M2.99M
Cash from Financing ActivitiesCash from Financing
0.46M0.99M0.36M0.65M0.13M1.64M17.57M135.13M-0.04M12.49M0.13M0.24M3.86M0.47M0.01M0.28M4.07M2.70M17.94M2.99M
Additional items
Change in Cash
-194.89M-92.79M-35.48M-30.06M-23.75M-5.59M13.45M37.86M-52.90M-1.76M-11.53M-5.90M-15.68M13.12M-4.22M-14.06M1.22M-0.30M14.09M-0.14M
Ending Cash Balance
240.47M147.68M112.19M82.13M58.38M52.79M66.24M104.10M51.21M49.45M37.91M32.02M16.34M29.46M25.25M11.19M12.41M12.10M26.19M26.06M
Free Cash FlowFCF
-22.07M-22.40M-24.49M-23.73M-26.80M-29.97M-17.74M-33.54M-23.66M-38.65M-35.11M-33.33M-35.99M-37.77M-28.68M-25.30M-20.62M-27.07M-22.80M-22.52M
Net Cash FlowNCF
-194.89M-92.79M-35.48M-30.06M-23.75M-5.59M13.45M37.86M-52.90M-1.76M-11.53M-5.90M-15.68M13.12M-4.22M-14.06M1.21M-0.32M14.08M-0.12M
Interest Paid
Income Taxes PaidTaxes Paid

Caribou Biosciences Cash Flow Statement API

Pull Caribou Biosciences's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=CRBU&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY